Literature DB >> 60625

Interaction of HLA molecules with non-immunological ligands as an explanation of HLA and disease associations.

A Svejgaard, L P Ryder.   

Abstract

It is postulated that alloantigens (HLA in particular) may interfere with ligand/receptor interactions not directly involved in immune reactions. This interference may be regarded as a side-effect of the creation of new mutant HLA alleles which are maintained in the population for other reasons. As an example, it is suggested that some HLA molecules may have structures resembling those on receptors for certain hormones which could cause competition between HLA and receptor molecules for the hormone. Facilitation of ligand/receptor interaction may also be envisaged. Such interactions could under certain conditions lead to disease and might explain some associations between HLA and non-immunological diseases (e.g., manic-depressive disease and haemachromatosis).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60625     DOI: 10.1016/s0140-6736(76)91796-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  The evidence justifying immunosuppression therapy in multiple sclerosis.

Authors:  J Mertin
Journal:  Proc R Soc Med       Date:  1977-12

2.  HLA-B18 is associated with decreased levels of isoproterenol-stimulated cAMP in lymphocytes.

Authors:  R P Erickson; G L Pairitz; J M Karolyi; J J Kapur; D J Odenheimer; J S Schultz; C F Sing
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

3.  HLA and disease 1980.

Authors: 
Journal:  Br Med J       Date:  1980-06-21

4.  Influence of H-2-linked genes on glucocorticoid receptors in the fetal mouse palate.

Authors:  M Katsumata; M K Baker; A S Goldman; D L Gasser
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Proximity measurements between H-2 antigens and the insulin receptor by fluorescence energy transfer: evidence that a close association does not influence insulin binding.

Authors:  T Liegler; J Szollosi; W Hyun; R S Goodenow
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  Hyperosmolar nonketotic diabetic coma.

Authors:  R Joosten; M Frank; H Hörnchen; J Bertrams
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183

7.  Haemochromatosis.

Authors:  A Bomford
Journal:  J R Soc Med       Date:  1979-05       Impact factor: 18.000

8.  HFE Related Hemochromatosis: Uncovering the Inextricable Link between Iron Homeostasis and the Immunological System.

Authors:  Graça Porto; Eugénia Cruz; Maria José Teles; Maria de Sousa
Journal:  Pharmaceuticals (Basel)       Date:  2019-08-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.